|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product revenue, net | |||||
| Development revenue | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| Cost of goods sold | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Impairment of long-lived assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Gain on bargain purchase | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Loss before income tax expense | |||||
| Income tax expense | |||||
| Net loss attributable to ordinary shareholders | |||||
| Net loss per ordinary share | |||||
| Basic net loss per share (in dollars per share) | |||||
| Diluted net loss per share (in dollars per share) | |||||
| Weighted average shares outstanding: | |||||
| Weighted Average Number of Shares Outstanding, Basic | |||||
| Weighted Average Number of Shares Outstanding, Diluted | |||||
Loading...